Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yacine Bareche
CTCs as a Prognostic and Predictive Biomarker for Stage II/III Colon Cancer: A Companion Study to the PePiTA Trial
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer
Oncotarget
Oncology
Expression of Aquaporin-1 Is a Poor Prognostic Factor for Stage II and III Colon Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients With Stage II/III Colorectal Cancer
Cancers
Cancer Research
Oncology
Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer
Scientific Reports
Multidisciplinary
Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study
Journal of Surgical Research
Surgery
P1.08-009 Neutrophilia as Prognostic Biomarker in Locally Advanced Stage III Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer
Clinical and Investigative Medicine
Medicine
Erratum: Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer (PePiTA): Protocol of a Prospective BGDO (Belgian Group for Digestive Oncology) Multicentric Study
BMC Cancer
Cancer Research
Oncology
Genetics
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer
Clinical Cancer Research
Cancer Research
Oncology
